AstraZeneca CEO: 2020 Approval For COVID Vaccine Still Possible
Soriot Says Speed Has Not Compromised Safety
Executive Summary
While AZ awaits an independent review, its CEO maintains the vaccine could soon be back on track for a late 2020/early 2021 approval.